Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia
| Class:Id | LiteratureReference:9965469 |
| _displayName | Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia |
| _timestamp | 2025-08-29 18:58:23 |
| author | [Person:5173300] Li, Wei [Person:9965464] Ji, Min [Person:6788829] Lu, Fei [Person:9965462] Pang, Yihua [Person:9929989] Dong, Xin [Person:9965465] Zhang, Jingru [Person:571189] Li, Peng [Person:6800626] Ye, Jingjing [Person:9965467] Zang, Shaolei [Person:9965466] Ma, Daoxin [Person:9965449] Ji, Chunyan |
| created | [InstanceEdit:9965463] Orlic-Milacic, Marija, 2025-08-29 |
| journal | Cell Death Dis |
| pages | 855 |
| pubMedIdentifier | 30154435 |
| title | Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia |
| volume | 9 |
| year | 2018 |
| (literatureReference) | [Reaction:9965437] The complex of MLLT11 and TCF7 binds CD44 gene promoter [Homo sapiens] [Summation:9965470] MLLT11 (AF1Q) enhances the binding affinity of the CTNNB1:TC... [Summation:9965489] MLLT11 (AF1Q), which forms a complex with TCF7 and CTNNB1... |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia (9965469)